StockData
Autonomix Medical, Inc. logo

Autonomix Medical, Inc. (AMIX) stock

AMIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.08−0.02 (-1.82%)

Close on Nov 17, 2026Market cap $1.05MP/E –Yield –

Autonomix Medical r&d expenses

Research and development expenses are spending on new products and technology.

Autonomix Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $7.07M, up 31.7% year over year. For fiscal 2026 it was $7.14M, up 51.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$7.14M+51.2%
FY2025Mar 31, 2025$4.73M+112.4%
FY2024Mar 31, 2024$2.23M+198.7%
FY2023Mar 31, 2023$745.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$1.52M-4.9%
Q4 FY2026CQ1 2026Mar 31, 2026$1.46M-6.0%
Q3 FY2026CQ4 2025Dec 31, 2025$1.72M+65.1%
Q2 FY2026CQ3 2025Sep 30, 2025$2.37M+101.6%
Q1 FY2026CQ2 2025Jun 30, 2025$1.59M+67.0%
Q4 FY2025CQ1 2025Mar 31, 2025$1.55M+122.5%
Q3 FY2025CQ4 2024Dec 31, 2024$1.04M+52.0%
Q2 FY2025CQ3 2024Sep 30, 2024$1.17M+149.3%
Q1 FY2025CQ2 2024Jun 30, 2024$954.00K+159.2%
Q4 FY2024CQ1 2024Mar 31, 2024$698.00K+71.5%
Q3 FY2024CQ4 2023Dec 31, 2023$687.00K+245.2%
Q2 FY2024CQ3 2023Sep 30, 2023$471.00K–
Q1 FY2024CQ2 2023Jun 30, 2023$368.00K–
Q4 FY2023CQ1 2023Mar 31, 2023$407.00K–
Q3 FY2023CQ4 2022Dec 31, 2022$199.00K–

More Autonomix Medical figures

See a number that looks wrong?